APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digital Health Solutions For Chronic Conditions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Health Solutions For Chronic Conditions Market Outlook and Growth Opportunities 2026

Report ID 17411697046 March 2026215 pages

Choose your research edition.

Industry ResearchDigital Health Solutions For Chronic Conditions Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Health Solutions For Chronic Conditions Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Digital Health Solutions For Chronic Conditions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Health Solutions For Chronic Conditions Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Health Solutions For Chronic Conditions Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Digital Health Solutions For Chronic Conditions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Health Solutions For Chronic Conditions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Health Solutions For Chronic Conditions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Health Solutions For Chronic Conditions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Health Solutions For Chronic Conditions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Health Solutions For Chronic Conditions market include DarioHealth, Teladoc Health, Voluntis, Sidekick Health, WellDoc, Mahalo Health, 2Morrow, Omada Health and ResMed, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Health Solutions For Chronic Conditions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Health Solutions For Chronic Conditions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Health Solutions For Chronic Conditions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Health Solutions For Chronic Conditions market.

Digital Health Solutions For Chronic Conditions Segment by Company

DarioHealth

Teladoc Health

Voluntis

Sidekick Health

WellDoc

Mahalo Health

2Morrow

Omada Health

ResMed

Virta Health

Bifourmis

Noom

Kaia Health

CureApp

Riva Health

Sweetch-Health

Lark Health

Vida Health

Mahana Therapeutics

Canary Health

Virgin Pulse

One Drop

Slanhealth

Digital Health Solutions For Chronic Conditions Segment by Type

Diabetes

Cardiovascular Diseases

Chronic Respiratory Diseases

Others

Digital Health Solutions For Chronic Conditions Segment by Application

Enterprise

Personal

Digital Health Solutions For Chronic Conditions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Health Solutions For Chronic Conditions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Health Solutions For Chronic Conditions key companies, revenue, market share, and recent developments.

3. To split the Digital Health Solutions For Chronic Conditions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Health Solutions For Chronic Conditions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Health Solutions For Chronic Conditions significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Health Solutions For Chronic Conditions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Health Solutions For Chronic Conditions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Health Solutions For Chronic Conditions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Health Solutions For Chronic Conditions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Health Solutions For Chronic Conditions industry.

Chapter 3: Detailed analysis of Digital Health Solutions For Chronic Conditions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Health Solutions For Chronic Conditions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Health Solutions For Chronic Conditions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Health Solutions For Chronic Conditions Industry Trends Table 2. Digital Health Solutions For Chronic Conditions Industry Drivers Table 3. Digital Health Solutions For Chronic Conditions Industry Opportunities and Challenges Table 4. Digital Health Solutions For Chronic Conditions Industry Restraints Table 5. Global Digital Health Solutions For Chronic Conditions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Health Solutions For Chronic Conditions Revenue Share by Company (2021-2026) Table 7. Global Digital Health Solutions For Chronic Conditions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Health Solutions For Chronic Conditions Key Company Manufacturing Base & Headquarters Table 9. Global Digital Health Solutions For Chronic Conditions Company, Product Type & Application Table 10. Global Digital Health Solutions For Chronic Conditions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Health Solutions For Chronic Conditions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Diabetes Table 15. Significant Companies of Cardiovascular Diseases Table 16. Significant Companies of Chronic Respiratory Diseases Table 17. Significant Companies of Others Table 18. Global Digital Health Solutions For Chronic Conditions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Digital Health Solutions For Chronic Conditions Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Digital Health Solutions For Chronic Conditions Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Type (2021-2026) Table 22. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Enterprise Table 24. Significant Companies of Personal Table 25. Global Digital Health Solutions For Chronic Conditions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digital Health Solutions For Chronic Conditions Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Digital Health Solutions For Chronic Conditions Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Application (2021-2026) Table 29. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Application (2027-2032) Table 30. Global Digital Health Solutions For Chronic Conditions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Health Solutions For Chronic Conditions Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Region (2021-2026) Table 33. Global Digital Health Solutions For Chronic Conditions Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Region (2027-2032) Table 35. Global Digital Health Solutions For Chronic Conditions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Digital Health Solutions For Chronic Conditions Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Digital Health Solutions For Chronic Conditions Sales Value Market Share by Country (2021-2026) Table 38. Global Digital Health Solutions For Chronic Conditions Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Digital Health Solutions For Chronic Conditions Sales Value Market Share by Country (2027-2032) Table 40. DarioHealth Company Information Table 41. DarioHealth Business Overview Table 42. DarioHealth Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. DarioHealth Digital Health Solutions For Chronic Conditions Product Portfolio Table 44. DarioHealth Recent Development Table 45. Teladoc Health Company Information Table 46. Teladoc Health Business Overview Table 47. Teladoc Health Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Teladoc Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 49. Teladoc Health Recent Development Table 50. Voluntis Company Information Table 51. Voluntis Business Overview Table 52. Voluntis Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Voluntis Digital Health Solutions For Chronic Conditions Product Portfolio Table 54. Voluntis Recent Development Table 55. Sidekick Health Company Information Table 56. Sidekick Health Business Overview Table 57. Sidekick Health Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Sidekick Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 59. Sidekick Health Recent Development Table 60. WellDoc Company Information Table 61. WellDoc Business Overview Table 62. WellDoc Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. WellDoc Digital Health Solutions For Chronic Conditions Product Portfolio Table 64. WellDoc Recent Development Table 65. Mahalo Health Company Information Table 66. Mahalo Health Business Overview Table 67. Mahalo Health Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Mahalo Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 69. Mahalo Health Recent Development Table 70. 2Morrow Company Information Table 71. 2Morrow Business Overview Table 72. 2Morrow Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. 2Morrow Digital Health Solutions For Chronic Conditions Product Portfolio Table 74. 2Morrow Recent Development Table 75. Omada Health Company Information Table 76. Omada Health Business Overview Table 77. Omada Health Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Omada Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 79. Omada Health Recent Development Table 80. ResMed Company Information Table 81. ResMed Business Overview Table 82. ResMed Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. ResMed Digital Health Solutions For Chronic Conditions Product Portfolio Table 84. ResMed Recent Development Table 85. Virta Health Company Information Table 86. Virta Health Business Overview Table 87. Virta Health Digital Health Solutions For Chronic Conditions Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Virta Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 89. Virta Health Recent Development Table 90. Bifourmis Company Information Table 91. Bifourmis Business Overview Table 92. Bifourmis Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Bifourmis Digital Health Solutions For Chronic Conditions Product Portfolio Table 94. Bifourmis Recent Development Table 95. Noom Company Information Table 96. Noom Business Overview Table 97. Noom Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Noom Digital Health Solutions For Chronic Conditions Product Portfolio Table 99. Noom Recent Development Table 100. Kaia Health Company Information Table 101. Kaia Health Business Overview Table 102. Kaia Health Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Kaia Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 104. Kaia Health Recent Development Table 105. CureApp Company Information Table 106. CureApp Business Overview Table 107. CureApp Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. CureApp Digital Health Solutions For Chronic Conditions Product Portfolio Table 109. CureApp Recent Development Table 110. Riva Health Company Information Table 111. Riva Health Business Overview Table 112. Riva Health Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Riva Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 114. Riva Health Recent Development Table 115. Sweetch-Health Company Information Table 116. Sweetch-Health Business Overview Table 117. Sweetch-Health Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Sweetch-Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 119. Sweetch-Health Recent Development Table 120. Lark Health Company Information Table 121. Lark Health Business Overview Table 122. Lark Health Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Lark Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 124. Lark Health Recent Development Table 125. Vida Health Company Information Table 126. Vida Health Business Overview Table 127. Vida Health Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Vida Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 129. Vida Health Recent Development Table 130. Mahana Therapeutics Company Information Table 131. Mahana Therapeutics Business Overview Table 132. Mahana Therapeutics Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Mahana Therapeutics Digital Health Solutions For Chronic Conditions Product Portfolio Table 134. Mahana Therapeutics Recent Development Table 135. Canary Health Company Information Table 136. Canary Health Business Overview Table 137. Canary Health Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Canary Health Digital Health Solutions For Chronic Conditions Product Portfolio Table 139. Canary Health Recent Development Table 140. Virgin Pulse Company Information Table 141. Virgin Pulse Business Overview Table 142. Virgin Pulse Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Virgin Pulse Digital Health Solutions For Chronic Conditions Product Portfolio Table 144. Virgin Pulse Recent Development Table 145. One Drop Company Information Table 146. One Drop Business Overview Table 147. One Drop Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. One Drop Digital Health Solutions For Chronic Conditions Product Portfolio Table 149. One Drop Recent Development Table 150. Slanhealth Company Information Table 151. Slanhealth Business Overview Table 152. Slanhealth Digital Health Solutions For Chronic Conditions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Slanhealth Digital Health Solutions For Chronic Conditions Product Portfolio Table 154. Slanhealth Recent Development Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Digital Health Solutions For Chronic Conditions Product Image Figure 2. Global Digital Health Solutions For Chronic Conditions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Health Solutions For Chronic Conditions Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Health Solutions For Chronic Conditions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Diabetes Image Figure 8. Cardiovascular Diseases Image Figure 9. Chronic Respiratory Diseases Image Figure 10. Others Image Figure 11. Global Digital Health Solutions For Chronic Conditions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Digital Health Solutions For Chronic Conditions Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Type (2021-2032) Figure 14. Enterprise Image Figure 15. Personal Image Figure 16. Global Digital Health Solutions For Chronic Conditions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Digital Health Solutions For Chronic Conditions Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Application (2021-2032) Figure 19. Global Digital Health Solutions For Chronic Conditions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Digital Health Solutions For Chronic Conditions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Digital Health Solutions For Chronic Conditions Sales Value (2021-2032) & (US$ Million) Figure 22. North America Digital Health Solutions For Chronic Conditions Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Digital Health Solutions For Chronic Conditions Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Digital Health Solutions For Chronic Conditions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Digital Health Solutions For Chronic Conditions Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Digital Health Solutions For Chronic Conditions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Digital Health Solutions For Chronic Conditions Sales Value (2021-2032) & (US$ Million) Figure 28. South America Digital Health Solutions For Chronic Conditions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Digital Health Solutions For Chronic Conditions Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Digital Health Solutions For Chronic Conditions Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Diabetes
  • Cardiovascular Diseases
  • Chronic Respiratory Diseases
  • Others
Applications
  • Enterprise
  • Personal
Companies covered
  • DarioHealth
  • Teladoc Health
  • Voluntis
  • Sidekick Health
  • WellDoc
  • Mahalo Health
  • 2Morrow
  • Omada Health
  • ResMed
  • Virta Health
  • Bifourmis
  • Noom
  • Kaia Health
  • CureApp
  • Riva Health
  • Sweetch-Health
  • Lark Health
  • Vida Health
  • Mahana Therapeutics
  • Canary Health
  • Virgin Pulse
  • One Drop
  • Slanhealth

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Health Solutions For Chronic Conditions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Health Solutions For Chronic Conditions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Health Solutions For Chronic Conditions Market Dynamics
  1. 2.1 Digital Health Solutions For Chronic Conditions Industry Trends
  2. 2.2 Digital Health Solutions For Chronic Conditions Industry Drivers
  3. 2.3 Digital Health Solutions For Chronic Conditions Industry Opportunities and Challenges
  4. 2.4 Digital Health Solutions For Chronic Conditions Industry Restraints
3 Digital Health Solutions For Chronic Conditions Market by Company
  1. 3.1 Global Digital Health Solutions For Chronic Conditions Company Revenue Ranking in 2025
  2. 3.2 Global Digital Health Solutions For Chronic Conditions Revenue by Company (2021-2026)
  3. 3.3 Global Digital Health Solutions For Chronic Conditions Company Ranking (2024-2026)
  4. 3.4 Global Digital Health Solutions For Chronic Conditions Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Health Solutions For Chronic Conditions Company Product Type and Application
  6. 3.6 Global Digital Health Solutions For Chronic Conditions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Health Solutions For Chronic Conditions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Health Solutions For Chronic Conditions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Health Solutions For Chronic Conditions Market by Type
  1. 4.1 Digital Health Solutions For Chronic Conditions Type Introduction
  2. 4.1.1 Diabetes
  3. 4.1.2 Cardiovascular Diseases
  4. 4.1.3 Chronic Respiratory Diseases
  5. 4.1.4 Others
  6. 4.2 Global Digital Health Solutions For Chronic Conditions Sales Value by Type
  7. 4.2.1 Global Digital Health Solutions For Chronic Conditions Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Digital Health Solutions For Chronic Conditions Sales Value by Type (2021-2032)
  9. 4.2.3 Global Digital Health Solutions For Chronic Conditions Sales Value Share by Type (2021-2032)
5 Digital Health Solutions For Chronic Conditions Market by Application
  1. 5.1 Digital Health Solutions For Chronic Conditions Application Introduction
  2. 5.1.1 Enterprise
  3. 5.1.2 Personal
  4. 5.2 Global Digital Health Solutions For Chronic Conditions Sales Value by Application
  5. 5.2.1 Global Digital Health Solutions For Chronic Conditions Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Digital Health Solutions For Chronic Conditions Sales Value by Application (2021-2032)
  7. 5.2.3 Global Digital Health Solutions For Chronic Conditions Sales Value Share by Application (2021-2032)
6 Digital Health Solutions For Chronic Conditions Regional Value Analysis
  1. 6.1 Global Digital Health Solutions For Chronic Conditions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Health Solutions For Chronic Conditions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Health Solutions For Chronic Conditions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Health Solutions For Chronic Conditions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Health Solutions For Chronic Conditions Sales Value (2021-2032)
  7. 6.3.2 North America Digital Health Solutions For Chronic Conditions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Health Solutions For Chronic Conditions Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Health Solutions For Chronic Conditions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Health Solutions For Chronic Conditions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Health Solutions For Chronic Conditions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Health Solutions For Chronic Conditions Sales Value (2021-2032)
  16. 6.6.2 South America Digital Health Solutions For Chronic Conditions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Health Solutions For Chronic Conditions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Health Solutions For Chronic Conditions Sales Value Share by Country, 2025 VS 2032
7 Digital Health Solutions For Chronic Conditions Country-level Value Analysis
  1. 7.1 Global Digital Health Solutions For Chronic Conditions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Health Solutions For Chronic Conditions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Health Solutions For Chronic Conditions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Health Solutions For Chronic Conditions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Health Solutions For Chronic Conditions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Health Solutions For Chronic Conditions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Health Solutions For Chronic Conditions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DarioHealth
  2. 8.1.1 DarioHealth Company Information
  3. 8.1.2 DarioHealth Business Overview
  4. 8.1.3 DarioHealth Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DarioHealth Digital Health Solutions For Chronic Conditions Product Portfolio
  6. 8.1.5 DarioHealth Recent Developments
  7. 8.2 Teladoc Health
  8. 8.2.1 Teladoc Health Company Information
  9. 8.2.2 Teladoc Health Business Overview
  10. 8.2.3 Teladoc Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teladoc Health Digital Health Solutions For Chronic Conditions Product Portfolio
  12. 8.2.5 Teladoc Health Recent Developments
  13. 8.3 Voluntis
  14. 8.3.1 Voluntis Company Information
  15. 8.3.2 Voluntis Business Overview
  16. 8.3.3 Voluntis Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Voluntis Digital Health Solutions For Chronic Conditions Product Portfolio
  18. 8.3.5 Voluntis Recent Developments
  19. 8.4 Sidekick Health
  20. 8.4.1 Sidekick Health Company Information
  21. 8.4.2 Sidekick Health Business Overview
  22. 8.4.3 Sidekick Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sidekick Health Digital Health Solutions For Chronic Conditions Product Portfolio
  24. 8.4.5 Sidekick Health Recent Developments
  25. 8.5 WellDoc
  26. 8.5.1 WellDoc Company Information
  27. 8.5.2 WellDoc Business Overview
  28. 8.5.3 WellDoc Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WellDoc Digital Health Solutions For Chronic Conditions Product Portfolio
  30. 8.5.5 WellDoc Recent Developments
  31. 8.6 Mahalo Health
  32. 8.6.1 Mahalo Health Company Information
  33. 8.6.2 Mahalo Health Business Overview
  34. 8.6.3 Mahalo Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mahalo Health Digital Health Solutions For Chronic Conditions Product Portfolio
  36. 8.6.5 Mahalo Health Recent Developments
  37. 8.7 2Morrow
  38. 8.7.1 2Morrow Company Information
  39. 8.7.2 2Morrow Business Overview
  40. 8.7.3 2Morrow Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 2Morrow Digital Health Solutions For Chronic Conditions Product Portfolio
  42. 8.7.5 2Morrow Recent Developments
  43. 8.8 Omada Health
  44. 8.8.1 Omada Health Company Information
  45. 8.8.2 Omada Health Business Overview
  46. 8.8.3 Omada Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Omada Health Digital Health Solutions For Chronic Conditions Product Portfolio
  48. 8.8.5 Omada Health Recent Developments
  49. 8.9 ResMed
  50. 8.9.1 ResMed Company Information
  51. 8.9.2 ResMed Business Overview
  52. 8.9.3 ResMed Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ResMed Digital Health Solutions For Chronic Conditions Product Portfolio
  54. 8.9.5 ResMed Recent Developments
  55. 8.10 Virta Health
  56. 8.10.1 Virta Health Company Information
  57. 8.10.2 Virta Health Business Overview
  58. 8.10.3 Virta Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Virta Health Digital Health Solutions For Chronic Conditions Product Portfolio
  60. 8.10.5 Virta Health Recent Developments
  61. 8.11 Bifourmis
  62. 8.11.1 Bifourmis Company Information
  63. 8.11.2 Bifourmis Business Overview
  64. 8.11.3 Bifourmis Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bifourmis Digital Health Solutions For Chronic Conditions Product Portfolio
  66. 8.11.5 Bifourmis Recent Developments
  67. 8.12 Noom
  68. 8.12.1 Noom Company Information
  69. 8.12.2 Noom Business Overview
  70. 8.12.3 Noom Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Noom Digital Health Solutions For Chronic Conditions Product Portfolio
  72. 8.12.5 Noom Recent Developments
  73. 8.13 Kaia Health
  74. 8.13.1 Kaia Health Company Information
  75. 8.13.2 Kaia Health Business Overview
  76. 8.13.3 Kaia Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Kaia Health Digital Health Solutions For Chronic Conditions Product Portfolio
  78. 8.13.5 Kaia Health Recent Developments
  79. 8.14 CureApp
  80. 8.14.1 CureApp Company Information
  81. 8.14.2 CureApp Business Overview
  82. 8.14.3 CureApp Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CureApp Digital Health Solutions For Chronic Conditions Product Portfolio
  84. 8.14.5 CureApp Recent Developments
  85. 8.15 Riva Health
  86. 8.15.1 Riva Health Company Information
  87. 8.15.2 Riva Health Business Overview
  88. 8.15.3 Riva Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Riva Health Digital Health Solutions For Chronic Conditions Product Portfolio
  90. 8.15.5 Riva Health Recent Developments
  91. 8.16 Sweetch-Health
  92. 8.16.1 Sweetch-Health Company Information
  93. 8.16.2 Sweetch-Health Business Overview
  94. 8.16.3 Sweetch-Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sweetch-Health Digital Health Solutions For Chronic Conditions Product Portfolio
  96. 8.16.5 Sweetch-Health Recent Developments
  97. 8.17 Lark Health
  98. 8.17.1 Lark Health Company Information
  99. 8.17.2 Lark Health Business Overview
  100. 8.17.3 Lark Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Lark Health Digital Health Solutions For Chronic Conditions Product Portfolio
  102. 8.17.5 Lark Health Recent Developments
  103. 8.18 Vida Health
  104. 8.18.1 Vida Health Company Information
  105. 8.18.2 Vida Health Business Overview
  106. 8.18.3 Vida Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Vida Health Digital Health Solutions For Chronic Conditions Product Portfolio
  108. 8.18.5 Vida Health Recent Developments
  109. 8.19 Mahana Therapeutics
  110. 8.19.1 Mahana Therapeutics Company Information
  111. 8.19.2 Mahana Therapeutics Business Overview
  112. 8.19.3 Mahana Therapeutics Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Mahana Therapeutics Digital Health Solutions For Chronic Conditions Product Portfolio
  114. 8.19.5 Mahana Therapeutics Recent Developments
  115. 8.20 Canary Health
  116. 8.20.1 Canary Health Company Information
  117. 8.20.2 Canary Health Business Overview
  118. 8.20.3 Canary Health Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Canary Health Digital Health Solutions For Chronic Conditions Product Portfolio
  120. 8.20.5 Canary Health Recent Developments
  121. 8.21 Virgin Pulse
  122. 8.21.1 Virgin Pulse Company Information
  123. 8.21.2 Virgin Pulse Business Overview
  124. 8.21.3 Virgin Pulse Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Virgin Pulse Digital Health Solutions For Chronic Conditions Product Portfolio
  126. 8.21.5 Virgin Pulse Recent Developments
  127. 8.22 One Drop
  128. 8.22.1 One Drop Company Information
  129. 8.22.2 One Drop Business Overview
  130. 8.22.3 One Drop Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  131. 8.22.4 One Drop Digital Health Solutions For Chronic Conditions Product Portfolio
  132. 8.22.5 One Drop Recent Developments
  133. 8.23 Slanhealth
  134. 8.23.1 Slanhealth Company Information
  135. 8.23.2 Slanhealth Business Overview
  136. 8.23.3 Slanhealth Digital Health Solutions For Chronic Conditions Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Slanhealth Digital Health Solutions For Chronic Conditions Product Portfolio
  138. 8.23.5 Slanhealth Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst